Welcome to our dedicated page for Uipath SEC filings (Ticker: PATH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The UiPath, Inc. (NYSE: PATH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, giving investors and researchers a structured view of how this software publisher reports on its automation and AI business. As a public company, UiPath files documents with the U.S. Securities and Exchange Commission, including current reports on Form 8-K and other periodic filings.
Recent Form 8-K filings for UiPath include results of operations and financial condition, where the company furnishes press releases announcing quarterly financial results. These filings typically reference revenue performance, Annualized Renewal Run-rate (ARR), dollar-based net retention rate, and other operating metrics, along with management commentary on the progress of UiPath’s agentic automation strategy. Another 8-K filing details matters submitted to a vote of security holders at the annual meeting, such as director elections, advisory votes on executive compensation, and ratification of the independent registered public accounting firm.
UiPath also uses Form 8-K to disclose other material events, such as the adoption of a Rule 10b5-1 trading plan by an entity controlled by its founder and chief executive officer. That filing explains the plan’s purpose within a personal long-term investment strategy and notes that the shares subject to the plan represent a limited portion of the individual’s holdings, while the individual remains a significant controlling stockholder.
On Stock Titan, UiPath filings are updated as they appear on EDGAR, and AI-powered summaries help explain the substance of each document. Users can quickly understand the context of earnings-related 8-Ks, governance disclosures, and other material events without reading every line of the underlying filing. For more detailed analysis, investors can review the full text of each filing alongside these AI-generated overviews.
UiPath (PATH) reported an insider transaction by its CEO and Chairman, who is also a 10% owner. On 10/24/2025, he sold 45,000 shares of Class A common stock in an open market sale pursuant to a Rule 10b5-1 trading plan. The sale price averaged $15.4578, with a disclosed range from $15.3200 to $15.5600.
Following the transaction, the reporting person beneficially owns 29,648,585 shares directly and 240,000 shares indirectly through a spouse.
UiPath (PATH) reported an insider transaction by its CEO and Chairman. On 10/23/2025, the reporting person sold 45,000 Class A shares at an average price of $15.1853, with a range of $15.0000–$15.3300, pursuant to a Rule 10b5-1 plan. Following the sale, beneficial ownership stood at 29,693,585 shares directly and 240,000 shares indirectly by spouse.
UiPath (PATH) insider transaction: The company’s CEO and Chairman, who is also a Director and 10% owner, reported selling 45,000 shares of Class A common stock on 10/22/2025 under a Rule 10b5-1 trading plan. The reported price was $15.5312, with trades executed in a range from $15.3700 to $15.8000.
Following the sale, the reporting person beneficially owns 29,738,585 shares directly and 240,000 shares indirectly through a spouse. This filing reflects a planned disposition under a qualified selling plan and provides price-range details upon request.
UiPath (PATH) insider transaction: The company’s Chief Accounting Officer reported selling 5,000 shares of Class A common stock on 10/22/2025 (Transaction Code S) under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $15.4673, with trade prices ranging from $15.3200 to $15.8000. Following this sale, the reporting person beneficially owns 182,776 shares, held directly.
UiPath (PATH) CEO and Chairman (also a Director and 10% Owner) reported a Form 4 sale of 45,000 Class A shares on 10/21/2025, executed under a Rule 10b5-1 trading plan. The weighted average price was $15.5692, with individual trade prices ranging from $15.4700 to $15.6800.
Following the transaction, the reporting person beneficially owns 29,783,585 shares directly and 240,000 shares indirectly through a spouse. The transaction code was S (open market sale).
UiPath (PATH) reported an insider transaction by its Chief Accounting Officer. On 10/21/2025, the officer sold 10,000 Class A shares at a price of $15.68 per share under a Rule 10b5-1 pre-arranged trading plan.
Following this sale, the officer beneficially owns 192,776 shares, held directly. This disclosure was filed on Form 4 and reflects a routine, planned transaction by a company officer.
UiPath, Inc. (PATH) CEO and Chairman reported an insider sale under a Rule 10b5-1 trading plan. On 10/20/2025, the reporting person sold 45,000 shares of Class A common stock at a price reported as $15.7116, with the filing noting a transaction price range from $15.6300 to $15.8700.
After this transaction, the reporting person beneficially owned 29,828,585 shares directly, and an additional 240,000 shares indirectly through a spouse. The individual is listed as a Director, 10% Owner, and Officer (CEO and Chairman). The sale was executed pursuant to a qualified selling plan adopted under Rule 10b5-1.
UiPath (PATH) Form 4: The company’s Chief Accounting Officer reported a sale of Class A common stock. On 10/20/2025, the officer sold 10,000 shares at $15.65 per share, disclosed with transaction code “S”. The filing notes the sale was made under a qualified Rule 10b5-1 trading plan.
Following this transaction, the reporting person beneficially owns 202,776 shares with direct ownership.
UiPath (PATH) reported an insider transaction by its Chief Accounting Officer. On 10/17/2025, the officer sold 10,000 shares of Class A common stock at an average price of $15.7345, executed under a qualified Rule 10b5-1 trading plan. Following the sale, the officer beneficially owns 212,776 shares directly. The filing notes a transaction price range from $15.6000 to $15.8700.
Form 144 filing: A holder filed notice to sell up to 35,000 shares of common stock. The filing lists an aggregate market value of $557,550, an approximate sale date of 10/17/2025, execution through Morgan Stanley Smith Barney LLC, and NYSE as the exchange.
The shares to be sold were acquired as Restricted Stock Units on 01/01/2024 in the amount of 35,000. Shares outstanding were 453,568,899 as of the filing’s disclosure.
The filer reported recent Rule 10b5-1 sales of 10,000 shares on 10/13/2025 ($170,056), 10/14/2025 ($165,351), 10/15/2025 ($166,801), and 10/16/2025 ($163,521).